Filing metadata

Accession number
0001209191-21-002691
Form type
Form 3
Filer
Damora Therapeutics, Inc.
CIK
CIK 1800315
Filed
Jan 08, 2021
Reporting period
Jan 08, 2021
Description
Initial ownership

Explore SEC Filings Hub